Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
MaSTherCell
MaSTherCell
Activities:
Manufacturing
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Catalent adds to regenerative therapy portfolio with $315m acquisition
Belgian CDMO MaSTherCell Global is a technology-focused cell and gene therapy CDMO
Manufacturing
MaSTherCell announces new cell and gene therapy facility in Belgium
The new facility will be built to manufacture late-stage and commercially-approved cell and gene therapy products on the Gosselies Biopark site
Estates & Facilities
Biotech manufacturing services agreement in Europe announced
MaSTherCell will manufacture tumour infiltrating lymphocyte for Iovance’s European late-stage clinical trials
Research & Development
CRISPR Therapeutics and MaSTherCell SA develop allogeneic cell therapies
CRISPR Therapeutics and MaSTherCell SA sign an agreement to develop and manufacture allogeneic CAR-T therapies
Manufacturing
Servier appoints MaSTherCell to develop its cell therapy manufacturing platform
MaSTherCell is developing CAR-T cell therapy manufacturing platform, enabling industrial manufacturing of Servier products
Manufacturing
TxCell signs strategic agreement with MaSTherCell to manufacture cell therapy products
Company commits to an ambitious product development schedule with two discovery platforms
Finance
Orgenesis acquires cell therapy manufacturer MaSTherCell
Acquisition to accelerate type 1 diabetes therapeutic into clinical trials and diversify future business model and product offering
Subscribe now